5nance5nance
5nance5nance
HomeScreens
LOGINGET FREE ACCOUNT

Vaishali Pharma Ltd.

•
vaishalipharma.comBSE: -NSE: VAISHALI
Market Cap₹ 113 Cr.
Current Price
High / Low₹ 13 / 5
Stock P/E26.6
Book Value₹ 6
Price to Book2.53
Dividend Yield0.00 %
ROCE5.0 %
ROE1.6 %
Face Value₹ 2

Add ratio to table

ABOUT

AI Sector View

AI GENERATED

Oil Gas & Consumable Fuels

Reduce

Sector economics are clouded by input volatility and uneven volume trends. WPI fuel inflation is very high at 20.05% (Jul/26), crude oil output is -5.3% YoY (2026-07), natural gas is -3.7% YoY (2026-07), and natural gas consumption is -3.0% YoY (2026-06), although refinery products grew 2.7% YoY (2026-07) and coal was 7.6% YoY (2026-07). Heavy FPI outflows of INR -15293 crore over 3 months to 2026-08-31 and negative oil-linked news flow reinforce the underweight.

Confidence
78%
View full sector analysis →

PROS

  • Promoters have been increasing their shareholding - up 5.3pp over 2 years
  • Company generates healthy free cash flow
  • Company maintains a comfortable, low leverage position

CONS

  • Operating cash flow has been negative in recent years
  • A large part of profit comes from other income (261.5% of PBT)
  • Poor cash conversion - profits are not backed by operating cash flow (CFO/PAT -1.98x)
  • Company has a low return on equity of 8.7% over last 3 years
  • Company has a low return on capital employed of 10.9%
  • Interest coverage is weak at 1.6x - earnings barely cover interest

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

Oil Gas & Consumable FuelsTradingTrading
Part ofNIFTY 50NIFTY 500NIFTY LARGEMIDCAP 250NIFTY 100NIFTY 200
S.No.Name
1.ADANIENT2886.0052.48390684.340.04-1461.54-249.6732923.9849.9213.3015.57
2.PREMIERENE1002.0027.3245485.940.10471.9253.322462.5935.2533.7229.03
3.AEGISLOG1286.1536.0845143.870.68544.84210.702356.8637.0719.7630.28
4.CPPLUS3748.5592.9144345.510.04142.20332.511402.4289.5129.4814.52
5.REDINGTON372.4017.1229113.281.61453.4994.6534922.4734.5718.962.03
6.HONASA477.4562.5515566.030.6390.45118.87755.9527.008.9914.58
7.LLOYDSENT71.9597.8110983.540.21109.98-55.77563.0370.1512.8418.07
8.SGMART814.5082.5710265.570.00455.801310.7113085.701044.0810.434.49
9.MMTC62.2820.889342.000.00104.24135.520.68-50.0033.46-1423.53
10.ENTERO1847.6064.128041.320.0052.0572.171940.5038.2310.935.00
11.CELLO343.5024.777747.240.4473.40-8.99526.72-0.4317.1518.80
12.VAISHALI8.2526.61112.860.0015.45—228.91—4.996.74
Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
131328321821283224332527229
111025391618273822322327217
Operating Profit233-7221-6112-012
OPM %17.21%21.16%10.61%-20.93%12.94%11.64%4.87%-18.73%5.77%4.16%6.33%-0.74%5.03%
0001011111116
Interest0000000000112
Depreciation0000000000001
Profit before Tax223-6232-6222017
Tax %25.00%27.97%26.22%26.95%25.11%25.10%25.39%23.39%26.44%28.31%28.57%-50.00%13.97%
Net Profit222-5221-4111015
1.501.611.99-4.370.150.150.98-0.330.10-0.490.100.020.11

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
67646875605476708699108
66606573595169608598104
Operating Profit13321379214
OPM %0.82%5.43%4.12%2.77%1.50%4.92%9.08%13.46%1.93%0.58%3.62%
31222222234
Interest33333322222
Depreciation00000001101
Profit before Tax-01110169115
Tax %-741.67%31.24%40.72%36.99%58.56%25.51%29.76%25.35%22.37%33.32%21.18%
Net Profit-01110147114
EPS0.000.000.000.000.030.993.825.910.670.06—
Dividend Payout %0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%—

COMPOUNDED SALES GROWTH

10 Years:
0%
5 Years:
11%
3 Years:
9%

COMPOUNDED PROFIT GROWTH

10 Years:
18%
5 Years:
90%
3 Years:
-41%

STOCK PRICE CAGR

10 Years:
—
5 Years:
17%
3 Years:
-13%
1 Year:
-32%

RETURN ON EQUITY

10 Years:
8%
5 Years:
9%
3 Years:
9%
Last Year:
2%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Corporate actions

2024

Oct 15

1:1

Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Equity Capital0377111111111126
311415111216222539
2021181616162013119
Trade Payables25152225244128181927
244657714139
Total Liabilities494564696686817980110
1111111222
3121111305
000000004947
Cash & Bank1000001122
43426066638378722654
Total Assets494564696686817980110

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
51-9442231-18
Cash from Investing311-0-0-0-101-0
Cash from Financing-8-18-4-3-20-2-118
0-000001-010

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
PER SHARE
EPS (₹)-0.612.371.211.080.030.993.826.260.670.06
Book Value (₹)64.0913.2531.2632.4720.2721.2624.9931.2633.414.98
Dividend per Share (₹)0.000.000.000.000.000.000.000.000.000.00
Cash EPS (₹)0.070.030.100.090.040.140.420.670.110.10
PROFITABILITY
Operating Margin %5.59%6.89%6.57%5.41%5.12%8.29%11.44%16.66%1.93%0.58%
Net Margin %-0.05%1.11%1.18%0.95%0.05%1.95%5.31%9.48%0.83%0.83%
ROE %-0.94%19.80%6.49%3.40%0.15%4.78%16.50%22.26%2.09%1.62%
ROCE %12.80%16.18%12.75%9.80%6.89%10.33%18.87%21.92%5.82%4.99%
-0.06%1.51%1.47%1.08%0.05%1.38%4.81%8.24%0.91%0.86%
EFFICIENCY
Debtor Days205222221228293386301294218177
Inventory Days18138765310710
Payable Days1231301151251722541981559299
10010511411112713710614913488
FINANCIAL HEALTH
Debt to Equity (x)6.56x5.75x0.89x0.80x0.78x0.78x0.79x0.41x0.35x0.18x
Interest Coverage (x)1.00x1.33x1.47x1.43x1.03x1.53x3.30x4.92x1.41x1.59x
1.14x1.07x1.45x1.48x1.51x1.37x1.47x2.27x2.25x2.61x
GROWTH
Revenue Growth %-29.46%-4.10%5.93%10.81%-19.98%-10.50%41.00%-8.12%23.85%14.77%
Operating Profit Growth %-6.11%18.17%0.99%-8.75%-24.35%45.00%94.60%33.82%-68.11%2.11%
Net Profit Growth %-118.76%2446.26%12.19%-10.54%-95.41%3091.33%284.58%64.12%-89.11%13.70%
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%-89.29%-90.65%
VALUATION
P/E (x)0.00x0.00x0.00x0.00x0.00x0.00x0.00x0.00x20.88x200.64x
P/B (x)0.00x0.00x0.00x0.00x0.00x0.00x0.00x0.00x4.19x2.53x
Dividend Yield %0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
0.00x0.00x0.00x0.00x0.00x0.00x0.00x0.00x43.54x46.02x

Shareholding Pattern

Numbers in percentages

Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
26.3226.3226.3226.3226.3226.3231.6131.6131.61
FIIs0.000.000.000.000.000.000.000.000.00
DIIs0.000.000.000.000.000.000.000.000.00
Government0.000.000.000.000.000.000.000.000.00
73.6873.6773.6873.6873.6873.6868.3968.3968.39

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-09-04
General Updates

2026-09-04 - Vaishali Pharma Limited has informed the Exchange about General Updates

2026-09-03
Copy of Newspaper Publication

2026-09-03 - Vaishali Pharma Limited has informed the Exchange about Copy of Newspaper Publication

2026-09-01
General Updates

2026-09-01 - Book Closure for the 19th AGM

2026-09-01
Record Date

2026-09-01 - Vaishali Pharma Limited has informed the Exchange that Record date for the purpose of Meeting is 17-Sep-2026.

2026-09-01
Shareholders meeting

2026-09-01 - Vaishali Pharma Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 24, 2026

2026-08-17
Copy of Newspaper Publication

2026-08-17 - Vaishali Pharma Limited has informed the Exchange about Copy of Newspaper Publication

2026-08-14
Resignation of Director/KMP/SMP

2026-08-14 - Vaishali Pharma Limited has informed the Exchange about Resignation of Director/KMP/SMP

2026-08-14
Resignation of Director/KMP/SMP

2026-08-14 - Vaishali Pharma Limited has informed the Exchange about Resignation of Director/KMP/SMP

2026-08-14
Resignation of Director/KMP/SMP

2026-08-14 - Vaishali Pharma Limited has informed the Exchange about Resignation of Director/KMP/SMP

News

Recent coverage and analyst commentary for VAISHALI

Loading news…

🤖

AI Stock Analyst

Vaishali Pharma Ltd.

🔒

Sign in to Chat with AI

Log in with your 5nance account to ask institutional questions about performance, financials, and outlook.

✨ Sign In to Chat

Free 5nance Account

5nance5nance

Stock analysis and screening tool

5nanceAI © 2020-2026

Made with ❤️ in India.

Data provided by Accord Fintech

Terms & Privacy.

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nance5nance

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme


5nanceAI © 2020-2026

Data provided by Accord Fintech

Made with ❤️ in India.

HomeScreens
Login